Navigation Links
Antibacterial Drugs Market 2015-2019 - Trends, Analysis, Key Players and Forecast
Date:11/18/2015

PORTLAND, Oregon, November 18, 2015 /PRNewswire/ --

Antibacterial drugs are chemical compounds used to treat infections caused by bacteria either by killing or inhibiting the growth of bacteria. The term antibiotic is often used synonymously with an antibacterial. However, antibiotics are agents that work against microorganisms such as bacteria, fungi, and parasites but are not effective against viruses. The term antibiotic was originally coined to refer to any compound of microbial origin, which is antagonistic to the growth of the microbe. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis. They can be bacteriostatic or bactericidal in nature, i.e., they either block vital processes in bacteria, kill the bacteria, or halt them from growing. Antibiotics that affect a wide range of bacteria are called broad-spectrum antibiotics (e.g., amoxicillin and gentamicin). Antibiotics that affect only a few types of bacteria are called narrow spectrum antibiotics (e.g., penicillin).

     (Logo: http://photos.prnewswire.com/prnh/20141014/710132)

To request more information about the report, visit the website at http://www.bigmarketresearch.com/global-antibacterial-drugs-2015-2019-market

As per the forecast the global antibacterial drugs market to grow at a CAGR of 1.06% over the period 2014-2019. 

Covered in this report 

The report covers the present scenario and growth prospects of the global antibacterial drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various prescription drugs along with the generic drugs used for the treatment of various infectious diseases caused by the different strains of bacteria. The various classes of antibacterial drug included in this report are beta-lactams, macrolides, aminoglycosides, phenicols, quinolones, folate antagonists, tetracyclines, and other miscellaneous agents, which include glycopeptides, nitroimidazoles, lincosamides, lipopeptides, nicotinic acid derivatives, and polypeptide antibiotics.

The report, Global Antibacterial Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global antibacterial drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market

Similar market research reports added by Big Market Research -  

Acute Bacterial Sinusitis Clinical Trials Review - http://www.bigmarketresearch.com/acute-bacterial-sinusitis-global-clinical-trials-review-h2-2015-market

Drugs Market for melanoma treatment - http://www.bigmarketresearch.com/global-drugs-for-melanoma-treatment-industry-2015-deep-research-report-market

Key regions 

• Americas

• APAC

• EMEA

Key vendors 

• Allergan

• GlaxoSmithKline

• Merck

• Novartis

• Pfizer

• Teva Pharmaceuticals

Key market driver 

• Special regulatory designations

• For a full, detailed list, view our report

Key market challenge 

• Development of drug-resistant strains

• For a full, detailed list, view our report

Key market trend 

• Strategic alliances and M&A

• For a full, detailed list, view our report

Key questions answered in this report 

• What will the market size be in 2019 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

About Us:    

With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:
Dhananjay Potle
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Direct: + 1-503-894-6022
Toll Free: + 1-800-910-6452
Email: help@bigmarketresearch.com

Web: http://www.bigmarketresearch.com

Blog: http://www.bigmarketresearch.blogspot.com



'/>"/>
SOURCE Big Market Research
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Destiny Pharma Announces Qualified Infectious Disease Product Designation Granted by US FDA for Novel Antibacterial Product
2. Antibacterial Drugs Market Expected to Reach USD 38.9 Billion Globally in 2023, at CAGR of 1.3% From 2015 to 2023: Transparency Market Research
3. Development and Commercialization of Antibacterial Drugs to Speed Up
4. Antibacterial Drugs Market (By Class and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
5. Kalorama: Acquisitions Trending in Dermatological Drugs Market
6. Eliminating Barriers to Treatment for Patients with HCV Who Inject Drugs
7. Erectile Dysfunction Drugs Market Worth $3.2 Billion By 2022: Grand View Research, Inc.
8. Isis Pharmaceuticals Reports Positive Clinical Data From Lp(a) Lowering Drugs
9. China Nepstar Chain Drugstore to Report Third Quarter 2015 Financial Results on November 25, 2015
10. General Anaesthesia Drugs Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2025
11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 2015-2019 with GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck & Co & Tesaro Dominating
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... , ... June 11, 2019 , ... ... Center and Grayken Center for Addiction will help combat the opioid epidemic by ... combines two pharmacy-specific educational interventions that have shown promise in reducing opioid-related harms, ...
(Date:6/11/2019)... ... June 11, 2019 , ... Intalere, ... today announced the latest enhanced release of OptiAnalytics Navigate. This best-in-class strategic ... customers. , “We are thrilled to offer these customer-focused new features ...
(Date:6/11/2019)... ... June 11, 2019 , ... MabPlex ... Organization (CDMO) serving the global biopharmaceutical and biotechnology industries with sites in China ... the company's new Chief Executive Officer (CEO). Dr Chen will be responsible for ...
Breaking Medicine Technology:
(Date:6/13/2019)... ... June 13, 2019 , ... ... SGLT-2 Inhibitors” presented at the American Diabetes Association (ADA) Scientific Sessions 2019 involving ... being treated with an SGLT-2 inhibitor. SGLT-2 inhibitors are used to lower glucose ...
(Date:6/12/2019)... ROCHELLE, Va. (PRWEB) , ... June 12, 2019 ... ... that Andrea Miller, a quality assurance expert with more than 25 years of ... and MDD Compliance for all classes of medical devices, has joined NDA Partners ...
(Date:6/12/2019)... ... June 12, 2019 , ... Ovation Travel Group, ... today announced that its Chairman and CEO Paul Metselaar has received the Children’s ... last Wednesday evening at New York City’s Capitale as part of the Children’s ...
(Date:6/12/2019)... ... June 12, 2019 , ... Millions of people across ... from participating in education or the workforce, and even from accessing health care. ... as a human right and address communication disability in ways that foster inclusion ...
(Date:6/11/2019)... ... 11, 2019 , ... The FSH Society today announced that ... regulators, biopharma companies, and academic thought leaders to discuss the current state of ... the world’s largest research-focused patient advocacy organization for FSHD, a hereditary muscle-damaging condition ...
Breaking Medicine News(10 mins):